These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 1649718)
1. Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin. De Marchi S; Cecchin E Clin Sci (Lond); 1991 Jul; 81(1):113-21. PubMed ID: 1649718 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin treatment in haemodialysis patients with iron overload. el-Reshaid K; Johny KV; Hakim A; Kamel H; Sebeta A; Hourani H; Kanyike FB Acta Haematol; 1994; 91(3):130-5. PubMed ID: 8091934 [TBL] [Abstract][Full Text] [Related]
3. Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients. Canavese C; Bergamo D; Ciccone G; Burdese M; Maddalena E; Barbieri S; Thea A; Fop F Nephrol Dial Transplant; 2004 Jun; 19(6):1564-70. PubMed ID: 15004263 [TBL] [Abstract][Full Text] [Related]
4. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload. Tarng DC; Huang TP Nephrol Dial Transplant; 1998 Nov; 13(11):2867-72. PubMed ID: 9829492 [TBL] [Abstract][Full Text] [Related]
5. Secondary haemochromatosis in a haemodialysis patient. Cheng L; Tang X; Fu P; Liu F Singapore Med J; 2015 Jul; 56(7):e124-6. PubMed ID: 26243982 [TBL] [Abstract][Full Text] [Related]
6. Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Gastaldello K; Vereerstraeten A; Nzame-Nze T; Vanherweghem JL; Tielemans C Nephrol Dial Transplant; 1995; 10 Suppl 6():44-7. PubMed ID: 8524494 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of hepatic computed tomography to detect iron overload in chronic hemodialysis. Cecchin E; De Marchi S; Querin F; Marin MG; Fiorentino R; Tesio F Kidney Int; 1990 Mar; 37(3):943-50. PubMed ID: 2313982 [TBL] [Abstract][Full Text] [Related]
9. Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy. Caravaca F; Vagace JM; Aparicio A; Groiss J; Pizarro JL; Alonso N; Garcia MC; Arrobas M; Cubero J; Esparrago J Am J Kidney Dis; 1992 Sep; 20(3):249-54. PubMed ID: 1519605 [TBL] [Abstract][Full Text] [Related]
10. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Kooistra MP; van Es A; Struyvenberg A; Marx JJ Br J Haematol; 1991 Dec; 79(4):634-9. PubMed ID: 1772785 [TBL] [Abstract][Full Text] [Related]
11. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients. Lazarus JM; Hakim RM; Newell J Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644 [TBL] [Abstract][Full Text] [Related]
14. Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: confirmation by follow-up liver biopsy. Onoyama K; Nakamura S; Yamamoto M; Kawadoko T; Nanishi F; Komoda T; Murai K; Fujishima M Nephron; 1990; 56(3):325-8. PubMed ID: 2077417 [TBL] [Abstract][Full Text] [Related]
15. Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Kooistra MP; Niemantsverdriet EC; van Es A; Mol-Beermann NM; Struyvenberg A; Marx JJ Nephrol Dial Transplant; 1998 Jan; 13(1):82-8. PubMed ID: 9481720 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis]. Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of iron overload in paediatric patients on chronic haemodialysis. Eijgenraam FJ; Donckerwolcke RA; van Dijken PJ Pediatr Nephrol; 1988 Jul; 2(3):303-8. PubMed ID: 3153030 [TBL] [Abstract][Full Text] [Related]
18. Treatment of iron overload in children and adolescents on chronic haemodialysis. Eijgenraam FJ; Donckerwolcke RA Eur J Pediatr; 1990 Feb; 149(5):359-62. PubMed ID: 2311634 [TBL] [Abstract][Full Text] [Related]
19. Importance of iron supply for erythropoietin therapy. Sunder-Plassmann G; Hörl WH Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170 [TBL] [Abstract][Full Text] [Related]
20. Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis. Borgna-Pignatti C; Castriota-Scanderbeg A Haematologica; 1991; 76(5):409-13. PubMed ID: 1806447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]